Exploring a Chronic and Painful Inflammatory Skin Disease : Episode 16

Opinion

Video

August 5, 2024

Optimizing Multidisciplinary Care of Patients with Hidradenitis Suppurativa

Author(s):

Vivian Shi, MD, FAAD

Vivian Shi, MD, FAAD, offers clinical insights on best practices for optimizing multidisciplinary care of patients with hidradenitis suppurativa.

EP: 1.Signs and Symptoms of Hidradenitis Suppurativa (HS)

EP: 2.Epidemiology and Impact of Hidradenitis Suppurativa

EP: 3.The Pathophysiology of Hidradenitis Suppurativa

EP: 4.Differential Diagnosis When Considering Hidradenitis Suppurativa in a Patient

EP: 5.Overview of the Hurley Staging System for Hidradenitis Suppurativa

EP: 6.Comorbidities and Coordinating Care Between Specialists in Hidradenitis Suppurativa

EP: 7.Hidradenitis Suppurativa: Addressing the Psychosocial Impact and Hospitalization Rate

EP: 8.The Impact of Hidradenitis Suppurativa on Families

EP: 9.Hidradenitis Suppurativa (HS): Staging Considerations and Unmet Needs

EP: 10.The Role of Treatment Guidelines for HS

EP: 11.Biologic Therapies for Hidradenitis Suppurativa

EP: 12.Recent Data on Bimekizumab for Hidradenitis Suppurativa

EP: 13.Ongoing Research in Hidradenitis Suppurativa

EP: 14.Managing Pain in Patients with Hidradenitis Suppurativa

EP: 15.The Role of Surgery in Hidradenitis Suppurativa

EP: 16.Optimizing Multidisciplinary Care of Patients with Hidradenitis Suppurativa

Video content above is prompted by the following question:

What are best practices for optimizing multidisciplinary care in patients with HS?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos

2 experts in this video

Related Content

Related Content

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions